Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|July 18, 2008
A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma modelEline Menu, Josefina Garcia, Xiangao Huang, et al.
European Journal of Medicinal Chemistry|January 1, 2025
Identification of a selective pyruvate dehydrogenase kinase 1 (PDHK1) chemical probe by virtual screeningMason A Baber, Mya D Gough, Larisa Yeomans, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
2-Aminoquinazoline inhibitors of cyclin-dependent kinasesYadagiri Bathini, Inderjit Singh, Patricia J Harvey, et al.
Journal of the American Chemical Society|March 6, 2009
Synthesis of (-)-PNU-286607 by asymmetric cyclization of alkylidene barbituratesJ Craig Ruble, Alexander R Hurd, Timothy A Johnson, et al.
Molecular Cancer Therapeutics|November 16, 2004
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenograftsDavid W Fry, Patricia J Harvey, Paul R Keller, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2009
Discovery and SAR of benzyl phenyl ethers as inhibitors of bacterial phenylalanyl-tRNA synthetaseJustin I Montgomery, Peter L Toogood, Kim M Hutchings, et al.
Journal of Medicinal Chemistry|April 2, 2005
Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4Scott N VanderWel, Patricia J Harvey, Dennis J McNamara, et al.
Nature Chemical Biology|January 7, 2015
Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonistsXiao Hu, Yahong Wang, Ling-Yang Hao, et al.
Journal of Medicinal Chemistry|April 2, 2005
Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6Peter L Toogood, Patricia J Harvey, Joseph T Repine, et al.
Pageof 3